In this study, we found that resibufogenin induced G1-phase arrest with the conversion of RB protein to the unphosphorylated form with down-regulation of cyclin D1 protein through the proteasomal degradation in human colon cancer HT-29 cells and human lung cancer A549 cells. Here, RB1 is linked to malignant colon neoplasm.